Disciplined Investors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$514K Sell
559
-16
-3% -$16.2K 0.31% 69
2025
Q4
$617K Buy
575
+23
+4% +$22K 0.41% 59
2025
Q3
$421K Buy
552
+213
+63% +$159K 0.3% 67
2025
Q2
$264K Buy
339
+46
+16% +$35.7K 0.21% 96
2025
Q1
$242K Buy
293
+34
+13% +$28.3K 0.22% 97
2024
Q4
$207K Buy
+259
New +$214K 0.2% 102

Other funds holding LLY

Disciplined Investors's LLY Position: Q1 2026 in Review

Disciplined Investors reduced its Eli Lilly (LLY) stake by 2.8% in Q1 2026, selling an estimated $16.2K and leaving 559 shares worth $514K. The position accounts for 0.31% of the portfolio, ranked #69.

Disciplined Investors first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $617K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Disciplined Investors held 559 shares of Eli Lilly worth $514K as of Q1 2026.
  • Disciplined Investors sold 16 Eli Lilly shares in Q1 2026, an estimated $16.2K.
  • Eli Lilly made up 0.31% of Disciplined Investors's portfolio in Q1 2026, its #69 holding.
  • Disciplined Investors first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Disciplined Investors's Eli Lilly position peaked at $617K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Disciplined Investors's 13F filing for Q1 2026, filed 12 May 2026.